TGFB1 and Parkinson disease: The results showed no significant correlations between serum IL-4, IL-10, and TGF-β concentrations in PD patients and patients' age, disease duration, disease severity (UPDRS-III score), and nonmotor symptoms (NMSS) (P > 0.05).